brain cancer

Contract research organisation (CRO), Reaction Biology, has partnered with an open science drug discovery and development company, M4K Pharma, in the fight against diffuse intrinsic pontine glioma (DIPG) — a rare paediatric brain cancer. Read more


After speaking openly about her brain cancer, the former minister for public health and culture secretary, Tessa Jowell, is now campaigning for cancer patients to have the choice to trial new treatments and stop the ones that aren’t working for them Read more


Biotech company, VAXIMM, has received orphan designation from the European Commission (EC) and the US Food and Drug Administration (FDA) for its lead product candidate, VXM01, for the treatment of glioma. Read more


An immunotherapy developed at Roswell Park Cancer Institute has been granted orphan drug status by the US Food and Drug Administration (FDA). Read more